Drawing for CATAXA

USPTO serial 78336555

CATAXA

Reviewed by CopyMark Law Group

Reg. 3124317Status 710
Filing date
Status date
Registration date
Aug 1, 2006
Examiner
HICKEY,TONI
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with CATAXA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher R. Lewis

Goods and services

ClassDescriptionStatusFirst use
001Catalysts used in the synthesis of chemicals for use in the pharmaceutical industry; anchored homogeneous catalysts used in the synthesis of chemicals for use in the pharmaceutical industry; anchored catalyst precursors used in the synthesis of chemicals for use in the pharmaceutical industry; chiral catalysts used in the synthesis of chemicals for use in the pharmaceutical industry; homogeneous precious metal catalysts used in the synthesis of chemicals for use in the pharmaceutical industry; anchored homogeneous precious metal catalysts used in the synthesis of chemicals for use in the pharmaceutical industry; precious metal-containing catalyst precursors used in the synthesis of chemicals for use in the pharmaceutical industry; chiral precious metal catalysts used in the synthesis of chemicals for use in the pharmaceutical industrySECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 8, 2013C8..CANCELLED SEC. 8 (6-YR)—
Aug 1, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 15, 2006REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
May 26, 2006ALIEASSIGNED TO LIE—
May 23, 2006CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
May 19, 2006SUPCSTATEMENT OF USE PROCESSING COMPLETE—
May 8, 2006IUAFUSE AMENDMENT FILED—
May 8, 2006EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jan 24, 2006NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 10, 2005ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Aug 9, 2005ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jul 12, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 22, 2005NPUBNOTICE OF PUBLICATION—
Apr 8, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 1, 2005ALIEASSIGNED TO LIE—
Mar 26, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 3, 2005TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 17, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 17, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 19, 2005CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 18, 2005CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 12, 2005TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 6, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 6, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 6, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 3, 2004DOCKASSIGNED TO EXAMINER—
Dec 30, 2003NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance